Cleared Traditional

K243656 - U2 Total Knee System – PF+ Patella

Also marketed or referenced as:
USTAR II System– PF+ Patella

K243656 is an FDA 510(k) clearance for U2 Total Knee System – PF+ Patella, manufactured by United Orthopedic Corporation. The device is a Class 2 Orthopedic device with product code MBH cleared through the Traditional 510(k) pathway after a 247-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2025
Decision
247d
Days
Class 2
Risk

K243656 is an FDA 510(k) clearance for the U2 Total Knee System – PF+ Patella. Classified as Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer (product code MBH), Class II - Special Controls.

Submitted by United Orthopedic Corporation (Hsinchu City, TW). The FDA issued a Cleared decision on July 31, 2025 after a review of 247 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3565 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all United Orthopedic Corporation devices

FDA 510(k) Submission Details - K243656

510(k) Number K243656 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 26, 2024
Decision Date July 31, 2025
Days to Decision 247 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
125d slower than avg
Panel avg: 122d · This submission: 247d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MBH Device Classification - Class 2, Special Controls

Product Code MBH Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3565
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

NJK & Associates, Inc.
Natalie J Kennel

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MBH Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer

All 141
Devices cleared under the same product code (MBH) and FDA review panel - the closest regulatory comparables to K243656.
Balanced Knee System TriMax Porous Femoral Components
K253161 · Ortho Development Corp. · Dec 2025
Freedom Metaphyseal Cone Implants (Metaphyseal Cones)
K252777 · Maxx Orthopedics, Inc. · Oct 2025
Triathlon® Total Knee System - Triathlon® Gold Femoral Components
K252044 · Howmedica Osteonics Corp., Dba Stryker Orthopaedics · Oct 2025
Physica System (Physica CR Porous Femoral components)
K250980 · Lima Corporate S.P.A. · May 2025
iTotal® Identity™ Cruciate Retaining 3DP Porous Knee Replacement System
K243768 · Restor3D, Inc. · Mar 2025
Freedom® Total Knee System - Porous Tibial Base Plate
K241597 · Maxx Orthopedics, Inc. · Feb 2025